Radiosensitization by the 2,4-dinitro-5-aziridinyl Benzamide CB 1954: A Structure/Activity Study

References

• Adams G.E., Ahmed I., Sheldon P.W., Stratford I.J. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. British Journal of Cancer 1984 a; 49: 571–577
   PubMed Web of Science ®Google Scholar
• Adams G.E., Ahmed I., Sheldon P.W., Stratford I.J. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo. International Journal of Radiation Oncology, Biology, Physics 1984 b; 10: 1653–1656
   PubMed Web of Science ®Google Scholar
• Adams G.E., Clarke E.D., Flockhart I.R., Jacobs R.S., Sehmi D.S., Stratford I.J., Wardman P., Watts M.E., Parrick J., Wallace R.G., Smithen L.E. Structure-activity relationships in the development of hypoxic cell radiosensitizers, I. Sensitization efficiency. International Journal of Radiation Biology 1979 a; 35: 133–150
   Web of Science ®Google Scholar
• Adams G.E., Clarke E.D., Gray P., Jacobs R.S., Stratford I.J., Wardman P., Watts M.E., Patrick J., Wallace R.G., Smithen C.E. Structure-activity relationships in the development of hypoxic cell radiosensitizers, II. Cytotoxicity and therapeutic ratio. International Journal of Radiation Biology 1979 b; 35: 151–160
   Google Scholar
• Adams G.E., Clarke E.D., Jacobs R.S., Stratford I.J., Wallace R.G., Wardman P., Watts M.E. Mammalian cell toxicity of nitro compounds: dependence upon reduction potential. Biochemical and Biophysical Research Communications 1976 a; 72: 824–829
   PubMed Web of Science ®Google Scholar
• Adams G.E., Flockhart I.R., Smithen C.E., Stratford I.J., Wardman P., Watts M.E. Electron-affinic sensitization, VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiation Research 1976 b; 67: 9–70
   PubMed Web of Science ®Google Scholar
• Chapman J.D., Raleigh J.A., Pedersen J.E., Ngan J., Shum F.Y., Meeker B.E., Urtason R.C. Potentially three distinct roles for hypoxic cell sensitizers in the clinic. Radiation Research: Proceedings of the 6th International Congress of Radiation Research, S. Okada, M. Immamura, T. Terashima, H. Yamaguchi. Japanese Association for Radiation Research, Tokyo 1979; 885–892
   Google Scholar
• Cobb L.M., Connors T.A., Elson L.A., Kahn A.H., Mitchley B.C.V., Ross W.C.J., Whisson M.E. 2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochemical Pharmacology 1969; 18: 1519–1527
   PubMed Web of Science ®Google Scholar
• Connors T.A., Mandel H.G., Melzack D.H. Studies on the reversal of the selective antitumour effect of the aziridinyl derivative CB 1954 by 4-amino-5-imidazole-carboxamide. International Journal of Cancer 1972; 9: 126–132
   Google Scholar
• Connors T.A., Melzack D.H. Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the Walker tumour. International Journal of Cancer 1971; 7: 86–92
   Google Scholar
• Creissen D., Shall S. Regulation of DNA ligase activity by poly (ADP ribose). Nature 1982; 296: 271–272
   PubMed Web of Science ®Google Scholar
• Dermer O.C., Ham G.E. Ethyleneimines and Other Aziridines. Academic Press, New York 1969
   Google Scholar
• Hickman J.A., Melzack D.H. Protection against the effects of the antitumour agent CB 1954 by certain imidazoles and related compounds. Biochemical Pharmacology 1975; 24: 1947–1952
   Google Scholar
• Hickman J.A., Melzack D.H. Studies on the protection by imidazoles against the cytotoxicity of the anitumour alkylating agents melphalan and CB 1954. Biochemical Pharmacology 1976; 25: 2489–2491
   Google Scholar
• Kandaiya S. Timescale of radiation damage by 2,4-dinitro-5-aziridinyl benzamide (CB 1954) in Chinese hamster cells: a rapid mix study. International Journal of Radiation Biology 1985; 48: 441–446
   Google Scholar
• Khan A.H., Ross W.C.J. Tumour-growth inhibitory nitrophenylaziridines and related compounds: structure-activity relationships. Chemico-Biological Interactions 1969/1970; 1: 27–47
   PubMedGoogle Scholar
• Khan A.H., Ross W.C.J. Tumour growth inhibitory nitrophenylaziridines and related compounds; structure-activity relationships II. Chemico-Biological Interactions 1971/1972; 4: 11–22
   Google Scholar
• Melzack D.M. Studies on the mechanism of action of the antitumour compound 5-aziridinyl-2,4-dinitrobenzamide (CB 1954). University of London. 1972, Ph.D. thesis
   Google Scholar
• Silver A.R.J., O'Neill P., Jenkins T.C. Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitiser. Role of binding of both unreduced and radiation-reduced forms of DNA. Biochemical Pharmacology 1985; 34: 3537–3542
   PubMed Web of Science ®Google Scholar
• Stratford I.J., Williamson C., Hoe S., Adams G.E. Radiosensitizing and cytotoxicity studies with CB 1954 (2,4-dinitro-5-aziridinylbenzamide). Radiation Research 1981; 88: 502–509
   Google Scholar
• Stratford I.J., Adams G.E., Hardy C., Hoe S., O'Neill P., Sheldon P.W. Thiol reactive nitroimidazoles; radiosensitization studies in vitro and in vivo. International Journal of Radiation Biology 1984; 46: 731–745
   Web of Science ®Google Scholar
• Walling J.M., Stratford I.J., Stephens M.A. Chemopotentiation by CB 1954: the importance of postincubations and the possible involvement of poly(ADP-ribosylation). International Journal of Radiation Oncology, Biology, Physics 1984; 10: 1661–1664
   Google Scholar
• Wardman P. Molecular structure and biological activity of hypoxic cell radiosensitizers and hypoxia specific cytotoxins. Advanced Topics on Radiosensitizers of Hypoxic Cells, A. Breccia, C. Rimandi, G.E. Adams. Nato Advanced Study Institutes Series A43, Plenum, New York 1982; 49–76
   Google Scholar